Levoxyl (levothyroxine sodium tablets, USP), 50 mcg, 100-count bottle, Rx only, Distributed by: Pfizer Inc., New York, NY 10017, Made in Austria, NDC 60793-851-01.
Class II · Ongoing
Subpotent drug
Advertisement
Advertisement
Affected lots / codes — check yours against thisLot #: 24C11, Exp 2/28/2026.
- Recalling firm
- Pfizer, Manhattan, NY
- Classification
- Class II (temporary or reversible harm possible)
- Status
- Ongoing
- Quantity
- 29, 004 bottles
- Distribution
- Within U.S
- Recall initiated
- July 29, 2025
- Classified
- August 8, 2025
- Initiation
- Voluntary: Firm initiated
Advertisement
Official source. This record is published by the U.S. FDA through the openFDA
enforcement database. View the unmodified government record:
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0575-2025%22
https://api.fda.gov/drug/enforcement.json?search=recall_number%3A%22D-0575-2025%22
Advertisement
Important. Recalls target specific lots and codes — compare the affected lots
above against your own product. This page reproduces public FDA data for readability;
EveryRecall is independent and not affiliated with the FDA.
Check this brand across all 8 databases →